The Harms of Psychedelics Must Be Put Into Context
In November 2021, when the psychedelics firm Compass Pathways launched the top-line outcomes of its trial psilocybin in sufferers with treatment-resistant melancholy, the inventory of the corporate plunged virtually 30 %. The dive was…